ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,877Hybrid

Transplant Infectious Disease

Acronym:tid
•
Abbreviation (ISO):TRANSPL INFECT DIS
•
Identifier (ISSN):1398-2273(Print)/1399-3062(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate IF (2026)
2.5↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Transplant Infectious Disease

WoS Q3
12341.8720182.1120192.0720202.2320212.620232.620242.620252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.803
#6,877

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
82

82 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate11.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
300articles/year
40.2% Gold OA•92.72% Original Research

Aims & Scope

Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.

Topics Covered (Recognized by AI)
Medicine99.9%Biology89.3%Internal medicine87.1%Surgery79.9%Genetics76.6%Transplantation69.2%Immunology66.6%Pathology64.9%Virology44%Chemistry40.2%Biochemistry36.7%Virus33.3%Microbiology29.5%Disease28.7%Endocrinology27.4%Family medicine25%Gastroenterology24.6%Intensive care medicine23.6%Human immunodeficiency virus (HIV)23.4%Mathematics22.8%Kidney22.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank128/183
IndexSCIE
JCRSCIE2026

INFECTIOUS DISEASES

Q3
Rank77/141
IndexSCIE
JCRSCIE2026

TRANSPLANTATION

Q2
Rank12/30
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank101/183
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q3
Rank75/141
IndexSCIE
JCISCIE2026

TRANSPLANTATION

Q2
Rank14/30
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year164
Total Citations30
2025
IF2.6
Articles / Year193
Total Citations285
2024
IF2.6
Articles / Year216
Total Citations668
2023
IF2.6
Articles / Year227
Total Citations1,354
2022
IF—
Articles / Year221
Total Citations1,642

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,877Scopus Q2SCImago Profile
Scopus Coverage:1999-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.803

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.84

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,099 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,119
3-Year Documents626
Citable Documents439

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2
TransplantationQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 11.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Transplant Infectious Disease (acronym: tid, abbr: TRANSPL INFECT DIS, ISSN: 1398-2273) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in United States since 1999. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.803 (Q2), an H-index of 82.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 300 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,099 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
1999
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8b093949-627c-4370-acdd-778879fc8d47
Database Updated: 2026-09-28